Prostate Cancer Daily

July 21, 2026

Videos

Peer-to-Peer Clinical Conversations

Doublet Versus Triplet Therapy in Metastatic Hormone-Sensitive Prostate Cancer - Neeraj Agarwal

Neeraj Agarwal

Neeraj Agarwal discusses doublet versus triplet selection in metastatic androgen pathway modulation-sensitive prostate cancer.

Patient Perspective on Radiographic Progression-Free Survival in Metastatic Prostate Cancer - David Matheson

David Matheson discusses the patient perspective on radiographic progression-free survival as a clinical trial endpoint.

Beyond the Abstracts

Quantifying the Renal Impact of [177Lu]Lu-PSMA-617: A Longitudinal Analysis of Real-World Data from the LUMEN Registry - Beyond the Abstract

Identification of Biomarkers Predictive of Successful Salvage Surgery in Prostate-specific Membrane Antigen Positron Emission Tomography-positive Oligorecurrent Prostate Cancer: Results from the BioPoP Trial - Beyond the Abstract

Conference Coverage

SNMMI 2026: Predictive Value of Baseline PSMA PET Imaging Biomarkers in 177Lu-DGUL Therapy: A Phase I/II trial Sub-analysis in mCRPC

ASCO 2026: An AI-Based Pathology Classifier to Predict Benefit from Enzalutamide in mHSPC from ENZAMET (ANZUP 1304)

AUA 2026: Duration of Treatment Suspension Among All Randomized Patients in EMBARK

APCCC 2026: How to Test for Relevant Molecular Alterations in mHSPC?

PSMA and Beyond 2026: Ac-PSMA: The Truth Should be Told!

Articles

Editor Selected Abstracts and Commentaries

Prostate Cancer

Structured robotic surgery training in Germany: a five-year evaluation of the German curriculum for robot-assisted radical prostatectomy.

EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II-2026 Update: Treatment of Relapsing and Metastatic Prostate Cancer.

EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2026 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent.

Genomic Classification to Predict Survival in Metastatic Prostate Cancer: Development of Somatic Tumor Risk Assessment for Overall Survival-Prostate.

Global research trends and hotspots in robotic-assisted prostate biopsy: a bibliometric analysis from 2008 to 2026.

CALB2 is a Mechanoresistance Gene in Metastatic Prostate Cancer.

ADT combinations with radiation for prostate cancer: A systematic review and meta-analysis.

Robust Meta-Analysis of a Clinical Cell-Cycle Risk (CCR) Score Demonstrates Broadly Applicable Metastasis and Disease-Specific Mortality Risk Stratification in Men With Localized Prostate Cancer - Beyond the Abstract

SBRT plus Abiraterone Acetate and ADT versus Abiraterone Acetate and ADT in Oligometastatic Castrate-Resistant Prostate Cancer (ARTO): Long-Term, Unplanned Overall Survival Analysis of an Open-Label, Randomised, Phase 2 Trial - Beyond the Abstract

CONNECT WITH US

Questions or Comments? Email us at editors@urotoday.com

Digital Science Press, LLC
2011 Phaethon Lane,
Reno, NV 89523

You are receiving this email because you have chosen to receive emails from UroToday.

Add us to your address book View this email as a web page Forward to a colleague Manage your subscriptions Unsubscribe

Copyright ©2026 Digital Science Press, LLC